Phase 3 Study: New Therapy Keeps Gastrointestinal Cancer Care on Course When Low Platelets Are an Obstacle
Newswise — MIAMI (March 16, 2026) – Cancer treatment is often described as a race against time. But for many patients, chemotherapy-induced thrombocytopenia (CIT) creates a roadblock—forcing clinicians to delay or reduce treatment. A new phase 3 clinical trial published in The New England Journal of Medicine suggests there may now be a way to … Read more